Drugmaker Teva has announced that the U.S. Food and Drug Administration has approved its generic form of the pain patch Duragesic for sale in the United States. According to a Teva press release, the generic--called the Fentanyl Transdermal System--will be available in 25 mcg/hour, 50 mcg/hour, 75 mcg/hour, and 100 mcg/hour dosages. Teva said they will begin shipping the generic pain patch immediately.
Read moreRecently, a question was asked by one reader as to whether a generic form of an erectile dysfunction medication is different than the... Read more »
Reader's Question: I have been told that Fosamax is coming out in generic form. I have been taking a brand name osteoporosis drug (in the... Read more »
It's been seven weeks since I had my baby. The time is really flying by and soon my maternity leave will be over. I've been slowly... Read more »
The U.S. Food and Drug Administration has approved the first generic version of Effexor XR (venlafaxine hydrochloride) to treat major depressive... Read more »
Drugmakers Atlana and Wyeth have sued Schwarz Pharma to stop the rival company from making a generic form of Protonix (pantoprazole). Schwarz Pharma... Read more »
Drugmaker Pfizer has once again stopped a generic form of Lipitor from hitting the market. A Danish court has issued an injunction to stop Ranbaxy... Read more »
Drugmaker Roche has filed a lawsuit against rival Teva Pharmaceuticals over a generic form of the osteoporosis med Boniva. Roche is trying to halt... Read more »
A Canadian court has blocked drugmaker Teva Pharmaceuticals from making a generic form of the pain med Celebrex. Teva had previously won a ruling... Read more »